MoMelan Technologies, Inc.
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2015–2015. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Momelan ranks #48,838 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.
- #48,838
- of 49,997 US assignees by volume
- 5th percentile
- by Innovation Score (18.9/100)
- 11.0
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R48838 · US Corporation #48,838 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #48,838/49,997
- PHOTO-FINISH Mironid
- CPC-NARROW A61B · 3 areas
- INNOV-LOW 18.9/100
- CLAIMS-PAR 11.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Mironid Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Momelan’s 18.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Momelan
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- MoMelan · this assignee 19
MoMelan · this assignee
19 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Momelan's Innovation Score is 18.9/100 (5th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Momelan?
Each dot is one of Momelan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Momelan’s own 11.0 claims/patent is at or below the 13.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Momelan's grants concentrate
MoMelan Technologies, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 60% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Momelan sits between Mironid Limited and Mobile Drive Technology Co., Ltd..
Who files at MoMelan's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mironid
Mironid Limited
5 patents
- Misfit
Misfit, Inc.
5 patents
- Mitokinin
Mitokinin, Inc.
5 patents
- Mitsubishi Chemic…
Mitsubishi Chemical Cleansui Corporation
5 patents
- Mobi
Mobi, LLC
5 patents
- Mobile Acuity
Mobile Acuity Limited
5 patents
- Mobile Climate Co…
Mobile Climate Control, Corp.
5 patents
- Mobile Drive Tech…
Mobile Drive Technology Co., Ltd.
5 patents
- Momelan ◀
MoMelan Technologies, Inc.
5 patents
What this shows MoMelan holds 5 patents at rank #48,881, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near MoMelan
By rank, the assignees closest to #48,881 in granted patent volume.
- Mironid Limited #48,877 · 5 patents
- Misfit, Inc. #48,878 · 5 patents
- Mitokinin, Inc. #48,879 · 5 patents
- Mitsubishi Chemical Cleansui Corporation #48,880 · 5 patents
- Mobi, LLC #48,882 · 5 patents
- Mobile Acuity Limited #48,883 · 5 patents
- Mobile Climate Control, Corp. #48,884 · 5 patents
- Mobile Drive Technology Co., Ltd. #48,885 · 5 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in MoMelan's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Momelan's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
19 5th percentile higher than 5% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 100.0% |
Which technologies does MoMelan Technologies, Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
MoMelan Technologies, Inc.'s patent record in context - here's where to go next.
- MoMelan Technologies, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 60% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #48,838 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare MoMelan Technologies, Inc. against Mironid Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 18.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.